JNJ vs SLB: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and SLB N.V. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-25.
Johnson & Johnson ยท Healthcare
$230.69
+10.8% upside to fair value
Grade C
High Quality
VS
SLB N.V. ยท Energy
$56.15
+45.0% upside to fair value
Grade B
QuantHub Verdict
SLB has more upside to fair value
(+45.0%).
SLB trades at a lower forward P/E
(24.3x).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
JNJ |
SLB |
| Current Price |
$230.69 |
$56.15 |
| Fair Value Estimate |
$255.61 |
$81.42 |
| Upside to Fair Value |
+10.8%
|
+45.0%
|
| Market Cap |
$555.9B |
$84.3B |
| Forward P/E |
26.8x
|
24.3x
|
| EV / EBITDA |
18.5x
|
17.5x
|
| Price / Sales |
5.8x
|
2.4x
|
| Price / FCF |
28.2x
|
17.6x
|
| Revenue Growth YoY |
+9.9%
|
+2.7%
|
| Gross Margin |
69.1%
|
13.6%
|
| Operating Margin |
26.9%
|
11.5%
|
| Return on Equity |
26.5%
|
12.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.54%
|
5.69%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,โฆ
SLB N.V. is the world's largest oilfield services company operating primarily in the energy sector with a focus on oil and gas equipment and services. The company benefits from a diversified revenue base across well construction, production systems, reservoir characterization, and digital integration, with fiscal year 2024 revenues totaling over $37 billion. Despite modest revenue growth of 2.7% โฆ
Accumulation Zones
| Metric |
JNJ |
SLB |
| Zone Low |
$191.71 |
$61.06 |
| Zone High |
$217.27 |
$69.21 |
| In Buy Zone? |
No
|
Yes
|